These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1. Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767 [TBL] [Abstract][Full Text] [Related]
3. NS1 Protein Mutation I64T Affects Interferon Responses and Virulence of Circulating H3N2 Human Influenza A Viruses. DeDiego ML; Nogales A; Lambert-Emo K; Martinez-Sobrido L; Topham DJ J Virol; 2016 Nov; 90(21):9693-9711. PubMed ID: 27535054 [TBL] [Abstract][Full Text] [Related]
4. NS1 Protein Amino Acid Changes D189N and V194I Affect Interferon Responses, Thermosensitivity, and Virulence of Circulating H3N2 Human Influenza A Viruses. Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML J Virol; 2017 Mar; 91(5):. PubMed ID: 28003482 [TBL] [Abstract][Full Text] [Related]
5. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. Haye K; Burmakina S; Moran T; García-Sastre A; Fernandez-Sesma A J Virol; 2009 Jul; 83(13):6849-62. PubMed ID: 19403682 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of host innate immune responses and pathogenicity of recombinant Newcastle disease viruses expressing NS1 genes of influenza A viruses. Kim SH; Samal SK J Gen Virol; 2010 Aug; 91(Pt 8):1996-2001. PubMed ID: 20410312 [TBL] [Abstract][Full Text] [Related]
7. A Promising IFN-Deficient System to Manufacture IFN-Sensitive Influenza Vaccine Virus. Chen C; Fan W; Li J; Zheng W; Zhang S; Yang L; Liu D; Liu W; Sun L Front Cell Infect Microbiol; 2018; 8():127. PubMed ID: 29765910 [TBL] [Abstract][Full Text] [Related]
8. Multiple anti-interferon actions of the influenza A virus NS1 protein. Kochs G; García-Sastre A; Martínez-Sobrido L J Virol; 2007 Jul; 81(13):7011-21. PubMed ID: 17442719 [TBL] [Abstract][Full Text] [Related]
9. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Hayman A; Comely S; Lackenby A; Murphy S; McCauley J; Goodbourn S; Barclay W Virology; 2006 Mar; 347(1):52-64. PubMed ID: 16378631 [TBL] [Abstract][Full Text] [Related]
10. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300 [TBL] [Abstract][Full Text] [Related]
11. A Naturally Occurring Deletion in the Effector Domain of H5N1 Swine Influenza Virus Nonstructural Protein 1 Regulates Viral Fitness and Host Innate Immunity. Wang J; Zeng Y; Xu S; Yang J; Wang W; Zhong B; Ge J; Yin L; Bu Z; Shu HB; Chen H; Lei CQ; Zhu Q J Virol; 2018 Jun; 92(11):. PubMed ID: 29563291 [TBL] [Abstract][Full Text] [Related]
12. MDCK cell line with inducible allele B NS1 expression propagates delNS1 influenza virus to high titres. van Wielink R; Harmsen MM; Martens DE; Peeters BP; Wijffels RH; Moormann RJ Vaccine; 2011 Sep; 29(40):6976-85. PubMed ID: 21787829 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with NS1-truncated H3N2 swine influenza virus primes T cells and confers cross-protection against an H1N1 heterosubtypic challenge in pigs. Kappes MA; Sandbulte MR; Platt R; Wang C; Lager KM; Henningson JN; Lorusso A; Vincent AL; Loving CL; Roth JA; Kehrli ME Vaccine; 2012 Jan; 30(2):280-8. PubMed ID: 22067263 [TBL] [Abstract][Full Text] [Related]
14. Attenuated influenza virus vaccines with modified NS1 proteins. Richt JA; García-Sastre A Curr Top Microbiol Immunol; 2009; 333():177-95. PubMed ID: 19768406 [TBL] [Abstract][Full Text] [Related]
15. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Geiss GK; Salvatore M; Tumpey TM; Carter VS; Wang X; Basler CF; Taubenberger JK; Bumgarner RE; Palese P; Katze MG; García-Sastre A Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10736-41. PubMed ID: 12149435 [TBL] [Abstract][Full Text] [Related]
16. The influenza virus NS1 protein: inhibitor of innate and adaptive immunity. Fernandez-Sesma A Infect Disord Drug Targets; 2007 Dec; 7(4):336-43. PubMed ID: 18220965 [TBL] [Abstract][Full Text] [Related]
17. Immune responses of mature chicken bone-marrow-derived dendritic cells infected with Newcastle disease virus strains with differing pathogenicity. Xiang B; Zhu W; Li Y; Gao P; Liang J; Liu D; Ding C; Liao M; Kang Y; Ren T Arch Virol; 2018 Jun; 163(6):1407-1417. PubMed ID: 29397456 [TBL] [Abstract][Full Text] [Related]
18. Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responses. Mueller SN; Langley WA; Carnero E; García-Sastre A; Ahmed R J Virol; 2010 Feb; 84(4):1847-55. PubMed ID: 19939929 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. Ferko B; Stasakova J; Romanova J; Kittel C; Sereinig S; Katinger H; Egorov A J Virol; 2004 Dec; 78(23):13037-45. PubMed ID: 15542655 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells. Forero A; Fenstermacher K; Wohlgemuth N; Nishida A; Carter V; Smith EA; Peng X; Hayes M; Francis D; Treanor J; Morrison J; Klein SL; Lane A; Katze MG; Pekosz A Vaccine; 2017 Oct; 35(45):6112-6121. PubMed ID: 28967519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]